FENNEC PHARMACEUTICALS INC. Other Current Assets
FENNEC PHARMACEUTICALS INC. (FENC) had Other Current Assets of $1.98 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2026-08-13
- 2026-06-30: Other Assets, Current $1.98M.
- 2026-03-31: Other Assets, Current $2.62M.
- 2025-12-31: Other Assets, Current $1.73M.
- 2025-09-30: Other Assets, Current $898.00K.
| Period end | Other Assets, Current |
|---|---|
| 2026-06-30 | $1.98M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $2.62M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $1.73M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $898.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $965.00K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $1.00M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $466.00K 10-K · filed 2026-03-27 |
| 2024-09-30 | $546.00K 10-Q · filed 2024-11-08 |
| 2024-06-30 | $283.00K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $161.00K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $44.00K 10-K · filed 2025-03-26 |
| 2023-09-30 | $20.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $32.00K 10-Q · filed 2023-08-07 |
| 2023-03-31 | $32.00K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $63.00K 10-K · filed 2024-03-29 |
| 2022-09-30 | $123.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $149.00K 10-Q · filed 2022-08-12 |
| 2022-03-31 | $154.00K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $253.00K 10-K · filed 2023-03-29 |
| 2021-09-30 | $412.00K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $372.00K 10-Q · filed 2021-08-10 |
| 2021-03-31 | $455.00K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $276.00K 10-K · filed 2022-02-28 |
| 2020-09-30 | $4.00K 10-Q · filed 2020-11-16 |
| 2020-06-30 | $4.00K 10-Q · filed 2020-08-05 |
| 2020-03-31 | $2.00K 10-Q · filed 2020-05-14 |
| 2019-12-31 | $8.00K 10-K · filed 2021-03-30 |
| 2019-06-30 | $1.00K 10-Q · filed 2019-08-09 |
| 2019-03-31 | $4.00K 10-Q · filed 2019-05-10 |
| 2018-12-31 | $1.00K 10-K · filed 2020-02-14 |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-13 |
| 2018-06-30 | $4.00K 10-Q · filed 2018-08-13 |
| 2018-03-31 | $10.00K 10-Q · filed 2018-05-14 |
| 2017-12-31 | $13.00K 10-K · filed 2019-03-15 |
| 2017-09-30 | $2.00K 10-Q · filed 2017-11-13 |
| 2017-06-30 | $6.00K 10-Q · filed 2017-08-14 |
| 2017-03-31 | $5.00K 10-Q · filed 2017-05-12 |
| 2016-12-31 | $3.00K 10-K · filed 2018-03-28 |
| 2016-09-30 | $2.00K 10-Q · filed 2016-11-14 |
| 2016-06-30 | $5.00K 10-Q · filed 2016-08-12 |
| 2016-03-31 | $3.00K 10-Q · filed 2016-05-12 |
| 2015-12-31 | $1.00K 10-K · filed 2017-03-29 |
| 2015-09-30 | $1.00K 10-Q · filed 2015-11-12 |
| 2015-06-30 | $3.00K 10-Q · filed 2015-08-11 |
| 2015-03-31 | $2.00K 10-Q · filed 2015-05-15 |
| 2014-12-31 | $17.00K 10-K · filed 2016-03-28 |
| 2014-09-30 | $13.00K 10-Q · filed 2014-11-13 |
| 2014-06-30 | $9.00K 10-Q · filed 2014-08-11 |
| 2014-03-31 | $3.00K 10-Q · filed 2014-05-15 |
| 2013-12-31 | $8.00K 10-K · filed 2015-03-31 |
| 2013-09-30 | $1.00K 10-Q · filed 2013-11-18 |
| 2013-06-30 | $3.00K 10-Q · filed 2013-08-09 |
| 2013-03-31 | $3.00K 10-Q · filed 2013-05-13 |
| 2012-12-31 | $6.00K 10-K · filed 2014-03-31 |
| 2012-09-30 | $6.00K 10-Q · filed 2012-11-14 |
| 2012-06-30 | $3.00K 10-Q · filed 2012-08-13 |
| 2012-03-31 | $14.00K 10-Q · filed 2012-05-15 |
| 2011-12-31 | $19.00K 10-K · filed 2013-04-01 |
| 2011-09-30 | $15.00K 10-Q · filed 2011-11-14 |
| 2011-06-30 | $8.00K 10-Q · filed 2011-08-15 |
| 2010-12-31 | $8.00K 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |